Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Market Cap	4.08B -19.3%
Revenue (ttm)	547.63M -18.1%
Net Income	187.84M -31.2%
EPS	2.34 -30.5%
Shares Out	80.74M
PE Ratio	21.58
Forward PE	19.42
Dividend	1.04 (2.06%)
Ex-Dividend Date	Jun 17, 2026

Volume	461,124
Open	50.62
Previous Close	50.63
Day's Range	50.26 - 51.22
52-Week Range	48.21 - 74.36
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic devices in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generators,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 779
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688581

Financial Performance

In 2025, Hangzhou AGS MedTech's revenue was 593.74 million, a decrease of -6.74% compared to the previous year's 636.63 million. Earnings were 221.71 million, a decrease of -24.43%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 13, 2026

Data Sources Report a data error